Synergistic Tissue Texture Stabilization via Enzyme Inhibition and Matrix Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current approaches to maintaining and improving the texture of living tissue, such as human skin and connective tissue, primarily focus on structure enhancement but fail to effectively counteract degenerative processes that lead to tissue degradation.
Innovation Solution
A synergistic preparation combining inhibitors of collagenase, elastase, and hyaluronidase with stimulators of tissue matrix formation, activators of blood vessel function, and neurotropic substances to stabilize and form tissue texture, using terpenoids, phytoacid components, vascular-active substances, and B vitamins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If only structure enhancement approaches are used, then tissue texture formation is improved, but degenerative processes are not effectively counteracted
Solution Approach 1:
The patent combines multiple functional components into a single preparation: A) collagenase/elastase inhibitors, B) tissue matrix formation stimulators, C) blood vessel function activators, and D) neurotropic substances. This merging of previously separate approaches creates a synergistic effect that simultaneously addresses both structure enhancement and protection against degenerative processes.
Solution Approach 2:
The invention creates a composite pharmaceutical preparation integrating four distinct types of active ingredients with different mechanisms of action. This composite approach allows the preparation to function both as a structure-building agent and as a protective agent against degradation, resolving the contradiction between formation and protection.
2Object-affected harmful factors
If enzyme inhibitors are used alone, then tissue degradation is reduced, but tissue matrix formation is insufficient
Solution Approach 1:
The patent merges enzyme inhibitors (component A) with tissue matrix formation stimulators (component B) into a single preparation. This combination ensures that while degradation is blocked by inhibitors, simultaneous formation is promoted by stimulants such as blueberry extract, hibiscus extract, and other acidic substances, achieving both protection and construction.
3Device complexity
If a single-component preparation is used, then the formulation is simple, but the effect on degenerative processes is insufficient
Solution Approach 1:
The patent combines four distinct functional components (A, B, C, D) into a single integrated preparation formulation. This merging maintains relative formulation simplicity while achieving comprehensive effectiveness through the synergistic interaction of multiple active ingredients targeting different aspects of tissue health.
Solution Approach 2:
The prepared formulation serves multiple functions simultaneously: it inhibits degradation enzymes, stimulates matrix formation, activates blood vessel function, and provides neurotropic support. This multi-functionality allows a single preparation to address various aspects of tissue degeneration and repair that would otherwise require separate treatments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination effectively counteracts degenerative processes, improving tissue texture and appearance by promoting structural stabilization and regeneration, as demonstrated by improved skin and hair follicle health in clinical studies.
Implementation Method 1
inhibitors of the breakdown of the tissue matrix by collagenase, elastase and hyaluronidase... substances A) are selected from A1) terpenoids... or from A2) phytoacid components... which are inhibitors of collagenase, elastase and/or hyaluronidase
Implementation Method 2
stimulators of tissue matrix formation... substances B) are selected from acidic substances such as blueberry/blueberry/lingonberry extract, hibiscus extract, Morinda citrifolia (noni fruit), pomegranate peel extract
Implementation Method 3
activators of blood vessel function... substances of group C) are selected from vascular-active substances such as calendula, marigold flower, white lily extract, tomato extract, niacin
Implementation Method 4
Activators of nerve function (neurotropic substances)... substances of group D) are selected from B vitamins, selected from B1, B2, B5, B6, B12
Data Source
Figure 1
Figure 2
AI summary
The invention relates in particular to synergistically acting preparations for stabilising and forming the texture of living tissue, in particular human skin and the appendages thereof such as, for example, hair follicles and nail beds as well as connective tissue, wherein said preparations comprise a combination of at least 2, preferably 3, in particular 4 basic constituents A+B, A+B+C and/or D, namely A) inhibitors of the breakdown of the tissue matrix by collagenase, elastase and hyaluronidase, B) stimulators of the tissue matrix formation, C) activators of blood vessel function and D) activators of nerve function (neurotropic substances). Surprisingly, such a combination in a synergistic (effect-enhancing) manner can be used to counteract degenerative processes consistent with the breakdown/ restructuring of the tissue texture. Therefore such preparations are suitable for systemic and topical as well as combined systemic-topical administration, above all for improving the function and thus the appearance and the texture of skin and the appendages thereof (skin texture forming, skin texture engineering) of living tissue having an increased breakdown function caused by age, trauma or disease.